Biotechnology Research Center, Tabriz University of Medical Science, Tabriz, Iran.
Student Research Committee, Tabriz University of Medical Science, Tabriz, Iran.
J Cell Mol Med. 2017 Sep;21(9):1668-1686. doi: 10.1111/jcmm.13110. Epub 2017 Feb 28.
Nanoparticulate drug/gene carriers have gained much attention in the past decades because of their versatile and tunable properties. However, efficacy of the therapeutic agents can be further enhanced using naturally occurring materials-based nanoparticles. Polysaccharides are an emerging class of biopolymers; therefore, they are generally considered to be safe, non-toxic, biocompatible and biodegradable. Considering that the target of nanoparticle-based therapeutic strategies is localization of biomedical agents in subcellular compartments, a detailed understanding of the cellular mechanism involved in the uptake of polysaccharide-based nanoparticles is essential for safe and efficient therapeutic applications. Uptake of the nanoparticles by the cellular systems occurs with a process known as endocytosis and is influenced by the physicochemical characteristics of nanoparticles such as size, shape and surface chemistry as well as the employed experimental conditions. In this study, we highlight the main endocytosis mechanisms responsible for the cellular uptake of polysaccharide nanoparticles containing drug/gene.
在过去的几十年中,由于其多功能和可调谐的特性,纳米颗粒药物/基因载体引起了广泛关注。然而,使用基于天然存在的材料的纳米粒子可以进一步提高治疗剂的功效。多糖是一类新兴的生物聚合物;因此,它们通常被认为是安全、无毒、生物相容和可生物降解的。鉴于基于纳米粒子的治疗策略的目标是将生物医学试剂定位在亚细胞隔室中,因此详细了解参与多糖基纳米粒子摄取的细胞机制对于安全有效的治疗应用至关重要。纳米颗粒被细胞系统摄取的过程称为内吞作用,并且受到纳米颗粒的物理化学特性(如大小、形状和表面化学性质)以及所采用的实验条件的影响。在本研究中,我们强调了负责含药物/基因的多糖纳米颗粒细胞摄取的主要内吞作用机制。